- Citation Copy to clipboard
McLendon K, Preuss CV
- PubMed ID
- 29262018 [ View in PubMed]
Atropine or atropine sulfate carries FDA indications for anti-sialagogue/anti-vagal effect, organophosphate/muscarinic poisoning, and bradycardia. Atropine acts as a competitive, reversible antagonist of muscarinic receptors: an anticholinergic drug. This activity outlines the indications, mechanism of action, safe administration, adverse effects, contraindications, toxicology, and monitoring of atropine.
DrugBank Data that Cites this Article